Endurance Wealth Management, Inc. Igm Biosciences, Inc. Transaction History
Endurance Wealth Management, Inc.
- $731 Million
- Q2 2023
A detailed history of Endurance Wealth Management, Inc. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Endurance Wealth Management, Inc. holds 300 shares of IGMS stock, worth $381. This represents 0.0% of its overall portfolio holdings.
Number of Shares
300Holding current value
$381% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding IGMS
# of Institutions
8Shares Held
942KCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY883KShares$1.12 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL45KShares$57,1690.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC12.6KShares$15,9700.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ400Shares$5080.0% of portfolio
-
Wipfli Financial Advisors Llc,108Shares$1370.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $36.8M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...